Skip to main content
Clinical Trial
Compass
Am I eligible?
Learn
Guides
Pricing
For teams
About
Sign in
Get started
Back to search
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer (NCT00002903) | Clinical Trial Compass